Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.555 USD | +0.91% | -2.97% | -16.79% |
Business Summary
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-03-31 |
Roy Golan
DFI | Director of Finance/CFO | 50 | 23-10-18 |
Shmuel Tuvia
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
General Counsel | - | 17-12-31 | |
Human Resources Officer | - | 18-12-31 | |
Dana Gelbaum
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 17-10-31 |
Roni Appel
BRD | Director/Board Member | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 17-11-30 |
Robert Spiegel
BRD | Director/Board Member | 73 | 17-11-30 |
Pini Orbach
BRD | Director/Board Member | - | 23-10-18 |
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-03-31 |
Director/Board Member | 53 | 20-07-31 | |
Bridget Martell
BRD | Director/Board Member | 58 | 23-10-18 |
Yuval Cabilly
BRD | Director/Board Member | 44 | 23-10-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,672,852 | 42,632,547 ( 99.91 %) | 39,452 ( 0.0925 %) | 99.91 % |
Company contact information
Ayala Pharmaceuticals, Inc.
9 Deer Park Drive Suite K-1
08852, Monmouth Junction
+
http://www.ayalapharma.comSector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.79% | 23.45M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- ADXS Stock
- Company Ayala Pharmaceuticals, Inc.